Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palisade Bio (PALI) Treasury Shares (2017 - 2023)

Historic Treasury Shares for Palisade Bio (PALI) over the last 9 years, with Q4 2023 value amounting to $24195.0.

  • Palisade Bio's Treasury Shares changed N/A to $24195.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $24195.0, marking a year-over-year change of. This contributed to the annual value of $24195.0 for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Palisade Bio's Treasury Shares is $24195.0.
  • Over the past 5 years, Palisade Bio's Treasury Shares peaked at $342970.0 during Q3 2023, and registered a low of $1907.0 during Q1 2020.
  • Moreover, its 4-year median value for Treasury Shares was $11972.0 (2019), whereas its average is $76628.2.
  • Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 8306.7% in 2020, then skyrocketed by 15259.57% in 2021.
  • Over the past 4 years, Palisade Bio's Treasury Shares (Quarter) stood at $11972.0 in 2019, then plummeted by 84.07% to $1907.0 in 2020, then soared by 362.35% to $8817.0 in 2021, then surged by 174.41% to $24195.0 in 2023.
  • Its Treasury Shares stands at $24195.0 for Q4 2023, versus $342970.0 for Q3 2023 and $241561.0 for Q2 2023.